Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019–21
Authors:
Abstract
Aims: The aim of this study was to characterize the circumstances of drug overdose deaths and determine whether naloxone administration differed by overdose decedent race and ethnicity.Design and setting: Analysis of data on unintentional and undetermined intent drug overdose deaths in Pennsylvania (2019–21) was collected from death certificates and the State Unintentional Drug Overdose Reporting System. Multivariable logistic regression models were adjusted for overdose death circumstances and the odds of naloxone administration were estimated by race/ethnicity and year.Cases: The analytical sample included 3386 fatal overdose decedents in 2019, 3864 in 2020 and 3816 in 2021.Measurements: Evidence of naloxone administration (yes/no) was defined using scene evidence and toxicology reports from coroner and medical examiner records, while race/ethnicity (Hispanic, non‐Hispanic Black, non‐Hispanic White) was based on the death certificate.Findings: In the analytic sample, overdose death rates were the highest among Black people and increased over time (rate per 10 000 population, 2019: 4.3; 2020: 6.1; 2021: 6.5); rates were lowest among White people and remained constant over time (rate per 10 000 population, 2019: 2.6; 2020: 2.7; 2021: 2.6). Throughout all years, Black decedents had approximately 40–50% lower odds of naloxone administration compared with White decedents as referent [2019: odds ratio (OR) = 0.7, 95% confidence interval (CI) = 0.5–0.9; 2020: OR = 0.5, 95% CI = 0.4–0.7; 2021: OR = 0.6, 95% CI = 0.5–0.8], while Hispanic decedents had similar odds of naloxone administration to that of White decedents.Conclusion: After controlling for overdose circumstances in drug overdose deaths in Pennsylvania, USA, from 2019 to 2021, Black people had lower odds of naloxone administration compared with White people, while there were no differences between Hispanic and White people.Keywords
Funding Information
- Centers for Disease Control and Prevention (NU17CE924973)
This publication has 34 references indexed in Scilit:
- Evaluating equity in community-based naloxone access among racial/ethnic groups in MassachusettsDrug and Alcohol Dependence, 2022
- Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019Drug and Alcohol Dependence, 2022
- Broadening access to naloxone: Community predictors of standing order naloxone distribution in MassachusettsDrug and Alcohol Dependence, 2021
- Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012–2019American Journal of Preventive Medicine, 2021
- Racial Disparities in Overdose Prevention among People Who Inject DrugsJournal of Urban Health, 2020
- Buprenorphine Treatment Divide by Race/Ethnicity and PaymentJAMA Psychiatry, 2019
- Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?International Journal of Drug Policy, 2017
- Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York CityDrug and Alcohol Dependence, 2016
- Variation in Use of Buprenorphine and Methadone Treatment by Racial, Ethnic, and Income Characteristics of Residential Social Areas in New York CityThe Journal of Behavioral Health Services & Research, 2013
- Trends in Opioid Prescribing by Race/Ethnicity for Patients Seeking Care in US Emergency DepartmentsJAMA, 2008